These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18596596)

  • 1. Menopause offers needed education.
    Menopause; 2008; 15(4 Suppl):777. PubMed ID: 18596596
    [No Abstract]   [Full Text] [Related]  

  • 2. Losing weight after menopause helps lower breast cancer risk.
    Mayo Clin Womens Healthsource; 2006 Dec; 10(12):3. PubMed ID: 17102789
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoprevention in postmenopausal women.
    Rastogi P
    Menopause; 2008; 15(4 Suppl):810-5. PubMed ID: 18596603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
    Col NF; Chlebowski RT
    Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?].
    Ringa V; Fournier A
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):297-301. PubMed ID: 18947946
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing the risk of breast cancer in postmenopausal women: introduction.
    Vogel VG
    Menopause; 2008; 15(4 Suppl):779-81. PubMed ID: 18596598
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
    Vogel VG
    Menopause; 2008; 15(4 Suppl):782-9. PubMed ID: 18596599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA; Land SR
    Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
    Vigneri R; Frasca F; Sciacca L; Vigneri P; Frittitta L
    J Natl Cancer Inst; 2009 Jul; 101(14):1030-1; author reply 1031-2. PubMed ID: 19546433
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast cancer and hormonal therapy.
    Conner P; Lundström E; von Schoultz B
    Clin Obstet Gynecol; 2008 Sep; 51(3):592-606. PubMed ID: 18677153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
    Chlebowski RT; Prentice RL
    J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
    [No Abstract]   [Full Text] [Related]  

  • 12. Menopause.
    Weismiller DG
    Prim Care; 2009 Mar; 36(1):199-226, x. PubMed ID: 19231610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trials of raloxifene: reducing the risk of osteoporosis and breast cancer in postmenopausal women.
    Olevsky OM; Martino S
    Menopause; 2008; 15(4 Suppl):790-6. PubMed ID: 18596600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk assessment for possible tailored screening for Japanese women.
    Tamaki Y; Kotsuma Y; Miyoshi Y; Noguchi S
    Breast Cancer; 2009; 16(4):243-7. PubMed ID: 19466509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the Gail model: lobular involution may help refine breast cancer risk assessment.
    Rowan K
    J Natl Cancer Inst; 2009 Feb; 101(3):134-5. PubMed ID: 19176450
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer risk elements and nurse practitioners' knowledge, use, and perceived comfort level of breast cancer risk assessment.
    Edwards QT; Maradiegue A; Seibert D; Saunders-Goldson S; Humphreys S
    J Am Acad Nurse Pract; 2009 May; 21(5):270-7. PubMed ID: 19432911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diet on breast cancer risk.
    Lof M; Weiderpass E
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):80-5. PubMed ID: 19125007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.
    Qin W; Zhu W; Hewett JE; Rottinghaus G; Chen YC; Flynn JT; Kliethermes B; Mannello F; Sauter ER
    BMC Cancer; 2008 Oct; 8():298. PubMed ID: 18922176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.